International Stem Cell Corp. - Company with Scores of Potential

International Stem Cell Corp (OTCBB:ISCO) is a company to watch this year, with several promising developments in store, according to a conference call with investors this morning.The company, whose parthenogenetic stem cell technology can be used to derive pluripotent stem...

Sign up: USDA June 29th deadline to halt dismantling GE Regs

Sign up: USDA June 29th deadline to halt GE, drug and industrial chemicals in food crops Many social welfare, health and environmental organizations are asking Americans to sign up before June 29 to halt the...

Diet Don't : Popcorn’s deadly butter-vapor diacetyl

A decade after safety concerns were first raised by experts, the Occupational Safety and Health Administration (OSHA) conducted public hearings on Diacetyl – a chemical widely used to flavor microwave popcorn. The public comment period ended on April 21st. Recent...

Weekly Radio Spin: Obama's Lobbying Stimulus

Listen to this week's edition of the "Weekly Radio Spin," the Center for Media and Democracy's audio report on the stories behind the news. This week, corporate healthcare gets the vapors, GM's new spinmeister and...

Biotechnology Seed Companies Accused of Thwarting Research

As anyone who has ever heard about what companies like Monsanto do behind closed doors would already know, biotechnology remains a gray, and apparently somewhat shady, area. There are growing concerns over the...

Hedge Funds to Cancer Patients: “Die.”

It is just what we have been saying all along. The thugs on wall street have been crushing the stocks of certain companies that do cancer research. Here is the undisputed proof of what has been going on with...

BioMS Medical Announces Q3 Results and Continues Pivotal Multiple Sclerosis T...

BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced financial and operational results for the third quarter ended September 30, 2008. BioMS Medical, in partnership with Eli Lilly and Company (Lilly), is developing...

Russian biotech scientist invents socks that keep feet smelling fresh

While his fellow scientists are trying to understand the origins of Bing Bang at CERN, Vladimir Rudenov is trying to get to the root of a scientific problem much closer to home…smelly feet. The concept is...

An Oil Giant's Green Dream

"If you've filled your tank with gas, or warmed your home with natural gas, there's a chance you sent money to Abu-Dhabi. So it might come as a surprise to learn that Abu Dhabi is this week hosting the world's first Future Energy Summit, a three-day gathering of more than...

XMAS GIFT: Designer House Cats

I'd rather give my spare cash to the Sally Ann Mission this Christmas. Guess the Paris Hiltons and other LaLa Celebrities will be giving themselves this holiday season?  Guess adopting everything from...

Microbe Petrol For Better Living :: MAXINE

"What would happen if technology could deliver a renewable way of creating gasoline in relative minutes as opposed to the millions and millions of years it takes to create the base of gasoline we pump out of the...

Pharm Animals Bred to Crank Out Drugs

This is a step beyond the purported 10-wing chickens being grown for KFC... Pharming raises all sorts of moral questions, primarily regarding the value of the life of an animal bred versus that of an animal born in the wild: animals experimented on are animals killed, which...

Top 25 Censored Stories of 2007

"#1 Future of Internet Debate Ignored by Media Sources: Buzzflash.com, July 18, 2005 Title: “Web of Deceit: How Internet Freedom Got the Federal Ax, and Why Corporate News Censored the Story” Author: Elliot D....

The vaccine to cure every strain of flu

"British scientists are on the verge of producing a revolutionary flu vaccine that works against all major types of the disease. Described as the 'holy grail' of flu vaccines, it would protect against all strains of influenza A - the virus behind both bird flu and the...

Study: Average biotech drug takes $1.2 billion, eight years to develop

BOSTON (AP) - The average drug manufactured by the biotechnology industry costs $1.2 billion and takes a little more than eight years to develop, according to a study released Thursday by the Tufts Center for the Study of Drug Development.

closeSign in to NowPublic

is reporting from